JP2020505324A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505324A5 JP2020505324A5 JP2019534141A JP2019534141A JP2020505324A5 JP 2020505324 A5 JP2020505324 A5 JP 2020505324A5 JP 2019534141 A JP2019534141 A JP 2019534141A JP 2019534141 A JP2019534141 A JP 2019534141A JP 2020505324 A5 JP2020505324 A5 JP 2020505324A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- peptide
- composition according
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762442441P | 2017-01-05 | 2017-01-05 | |
| US62/442,441 | 2017-01-05 | ||
| US201762481702P | 2017-04-05 | 2017-04-05 | |
| US62/481,702 | 2017-04-05 | ||
| US201762557153P | 2017-09-12 | 2017-09-12 | |
| US62/557,153 | 2017-09-12 | ||
| PCT/IL2018/050012 WO2018127914A1 (en) | 2017-01-05 | 2018-01-04 | Peptides for treating sjogren's syndrome |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020505324A JP2020505324A (ja) | 2020-02-20 |
| JP2020505324A5 true JP2020505324A5 (cg-RX-API-DMAC7.html) | 2021-02-12 |
| JP7242059B2 JP7242059B2 (ja) | 2023-03-20 |
Family
ID=61157250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019534141A Active JP7242059B2 (ja) | 2017-01-05 | 2018-01-04 | シェーグレン症候群の治療用ペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11167005B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3565574A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7242059B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110139659B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018205885A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3047706A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL267426B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018127914A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116287183B (zh) * | 2022-11-18 | 2023-11-03 | 中国医学科学院北京协和医院 | 一组用于诊断干燥综合征的分子标志物组合 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6613536B1 (en) | 1995-03-28 | 2003-09-02 | Yeda Research And Development Co. Ltd. | Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| IL141647A0 (en) * | 2001-02-26 | 2002-03-10 | Yeda Res & Dev | Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| NZ541659A (en) | 2003-01-14 | 2007-05-31 | Teva Pharma | Pharmaceutical composition comprising with a pH between 4 and 9 to treat SLE comprising an aqueous carrier, a pharmaceutically acceptable salt of a peptide and a substituted beta-cyclodextrin |
| DK1594434T3 (da) | 2003-01-14 | 2017-01-02 | Yeda Res & Dev Company Ltd At The Weizmann Inst Of Science | Parenterale formuleringer af peptide til behandling af systemisk lupus erythematosus |
| AU2005276117C1 (en) * | 2004-08-23 | 2013-04-18 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Peptide inhibitors for mediating stress responses |
| KR20080074120A (ko) * | 2005-10-13 | 2008-08-12 | 휴먼 게놈 사이언시즈, 인코포레이티드 | 자가항체 양성 질환 환자의 치료에 유용한 방법 및 조성물 |
| US20100322928A1 (en) | 2007-01-19 | 2010-12-23 | Yeda Research And Development Co., Ltd. | Methods of diagnosing, monitoring treatment and treating systemic lupus erythematosus (sle) |
| WO2014052393A2 (en) | 2012-09-25 | 2014-04-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods for the diagnosis and treatment of sjögren's syndrome |
| US20180043016A1 (en) | 2016-08-11 | 2018-02-15 | Xtl Biopharmaceuticals Ltd. | Pharmaceutical compositions comprising 0.25 mg dose of synthetic human peptides for treating systemic lupus erythematosus |
| US20180043017A1 (en) | 2016-08-11 | 2018-02-15 | Xtl Biopharmaceuticals Ltd. | Pharmaceutical compositions comprising 0.5 mg dose of synthetic human peptides for treating systemic lupus erythematosus |
-
2018
- 2018-01-04 US US16/474,831 patent/US11167005B2/en not_active Expired - Fee Related
- 2018-01-04 IL IL267426A patent/IL267426B2/en unknown
- 2018-01-04 CA CA3047706A patent/CA3047706A1/en active Pending
- 2018-01-04 AU AU2018205885A patent/AU2018205885A1/en not_active Abandoned
- 2018-01-04 JP JP2019534141A patent/JP7242059B2/ja active Active
- 2018-01-04 EP EP18703096.0A patent/EP3565574A1/en not_active Withdrawn
- 2018-01-04 WO PCT/IL2018/050012 patent/WO2018127914A1/en not_active Ceased
- 2018-01-04 CN CN201880005934.0A patent/CN110139659B/zh not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6084207B2 (ja) | 虚血性脳損傷及び疼痛治療用の効率的な神経保護剤としてのｐｓｄ−９５の高親和性二量体阻害剤 | |
| RU2194054C2 (ru) | Синтетические аналоги il-10 | |
| JP4848267B2 (ja) | Ｈｃｇ断片を含む粘膜及び経口投与のための組成物 | |
| JP2012506442A5 (cg-RX-API-DMAC7.html) | ||
| JP2014500868A (ja) | 癌及び慢性感染の治療のための作動薬活性を有するｉｌ−２由来のポリペプチド | |
| BRPI0912411B1 (pt) | Uso de uma muteína de interleucina humana-2 (muteína de hil-2) e composição farmacêutica para o tratamento e/ou profilaxia de uma doença autoimune | |
| NO326298B1 (no) | Anvendelse av R'-Glu-Trp-R'' dipeptider i fremstilling av medikamenter | |
| JP2019533722A5 (cg-RX-API-DMAC7.html) | ||
| JP2006506942A5 (cg-RX-API-DMAC7.html) | ||
| JP2023145635A (ja) | 免疫調節特性を有するペプチド | |
| ES2660894T3 (es) | Péptidos derivados de ezrina y composiciones farmacéuticas de los mismos | |
| US20050075277A1 (en) | Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects | |
| RU2010120571A (ru) | Тимус-специфический белок | |
| CN102776264B (zh) | 与凋亡或坏死相关的TNFα短肽及其应用 | |
| ES2338350T3 (es) | Utilizacion de hsp20 para estimular la cicatrizacion de heridas y/o para reducir la formacion de cicatrices. | |
| CN114080394B (zh) | 新型θ-防御素类似物 | |
| JP2007500693A (ja) | 移植片拒絶反応を予防するための合成ペプチドコポリマーを含む併用療法 | |
| CN107805282A (zh) | 一种靶向疗法和免疫疗法联合的多肽 | |
| ES2657049T3 (es) | IL-6 para la terapia o prevención de neuropatías inducidas por quimioterapia | |
| CN111788217A (zh) | 白介素-15活性的拮抗剂肽 | |
| JP7242059B2 (ja) | シェーグレン症候群の治療用ペプチド | |
| CN111574590B (zh) | 一种具有抗肿瘤功能的多肽及其应用 | |
| JP7437315B2 (ja) | 腸管における潰瘍または瘻孔の治療または予防のための医薬組成物 | |
| CN119874872B (zh) | 一种mita铰链区突变多肽及其在自身免疫性疾病中的应用 | |
| US20200071357A1 (en) | Antimicrobial peptides |